Cleerly

Cleerly is a digital healthcare company focused on advanced cardiac care through its AI-powered platform. This technology analyzes coronary computed tomography angiography (CCTA) images to assess and quantify coronary artery disease (CAD). Cleerly's proprietary, FDA-cleared machine learning algorithms provide non-invasive measurements of atherosclerosis, stenosis, and ischemia likelihood, generating detailed 3D models of patients' coronary arteries for precise evaluations. The company offers a range of services, including automated imaging analysis, comprehensive plaque and stenosis quantification, and ischemia detection. Clinicians receive interactive web-based reports that summarize findings and support diagnosis and treatment decisions. Cleerly also provides tools for tracking disease progression and enhancing patient education, all grounded in extensive clinical research and validated against invasive gold standards. Cleerly primarily serves healthcare providers, including cardiology practices and health systems, aiming to improve cardiovascular care through early detection, personalized treatment plans, and enhanced patient engagement.

• Employees 260
• Founded 2017
• Annual Revenue $40100000
• Total Funding $358393150